SanaClis acquisition of PPH plus assets strengthens pan-European service competency

Bratislava, Slovakia

Award-winning full-service CRO SanaClis s.r.o. has announced its asset acquisition of Frankfurt am Main, Germany, based contract research organization PPH plus GmbH & Co. KG.

The acquisition signals a significant expansion of SanaClis core operations from Central and Eastern Europe to Western Europe.

Ever-closer relationship

PPH plus provides significant operational and management consultancy services to clinical trial sponsors in Western European countries, especially in Germany and Austria.

“This acquisition stems from a long-established and ever closer professional relationship between the SanaClis and PPH plus management,” said SanaClis Managing Partner Alexander Fetkovsky.

Europe-wide coverage

“The acquisition of PPH plus assets strengthens our combined ability to offer leading-edge full-service clinical research and support services right across Europe, with very considerable opportunity to benefit from pooling our impressive expertise and knowledge,” he added.

“It allows us to grow our capabilities and country coverage,” said Mr. Fetkovsky, as underlined by Dr. med. Johanna Schenk, FFPM, Managing Director and COO, PPH plus, by adding that “PPH plus is extremely delighted to join forces with SanaClis on this important move to operationally and geographically enhanced customer services”.

In addition to classical CRO services such as clinical monitoring and project management, regulatory affairs, data management and biostatistics, SanaClis also offers IMP management services in European countries via a network of GxP compliant warehouses. This is enhanced by its groundbreaking IMP/CTS warehouse management software.

Press Release